Alcon Dionica

Alcon ROE

ROE (Return on Equity) tvrtke Alcon (ALC.SW) na dan 23. kol 2026. iznosi 4,66 %. Prethodne godine ROE (Return on Equity) je iznosio 4,72 % — promjena od −1,29% (manji).

ROE

4,66 %

YoY

−1,29%

Zadnje ažuriranje:

U godini 2026 povrat na vlastiti kapital (ROE) od Alcon iznosio je 4,66 %, porast za −1,29% u odnosu na 4,72 % ROE prethodne godine.

Povijest Alcon ROE

  • 3 godine

  • 10 godina

  • 25 godina

  • Max

ROE
Date
ROE
1. sij 2018.
−1,61 USD
1. sij 2019.
−3,40 USD
1. sij 2020.
−2,82 USD
1. sij 2021.
1,95 USD
1. sij 2022.
1,70 USD
1. sij 2023.
4,72 USD
1. sij 2024.
4,72 USD
1. sij 2025.
4,66 USD
Povijest Alcon ROE
GODINAROEYoY
4,66 %−1,29%
4,72 %+0,01%
4,72 %+177,40%
1,70 %−12,81%
1,95 %−169,21%
−2,82 %−16,99%
−3,40 %+110,54%
−1,61 %−245,20%
1,11 %−250,48%
−0,74 %−156,69%
1,30 %
Access this data via the Eulerpool API

Alcon Analiza dionica

Što radi Alcon? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon je jedna od najpopularnijih tvrtki na Eulerpool.com.

ROE u detalje

Otključavanje povrata na vlastiti kapital (ROE) od Alcon

Povrat na vlastiti kapital (ROE) od Alcon je osnovni pokazatelj koji procjenjuje profitabilnost tvrtke u odnosu na vlastiti kapital. ROE, izračunat dijeljenjem neto dobiti s vlastitim kapitalom dioničara, ilustrira koliko učinkovito tvrtka ostvaruje dobit iz investicija svojih dioničara. Viši ROE predstavlja veću efikasnost i profitabilnost.

Usporedba iz godine u godinu

Analiza ROE od Alcon na godišnjoj razini pomaže pratiti trendove profitabilnosti i financijsku izvedbu. Rastući ROE ukazuje na povećanu profitabilnost i stvaranje vrijednosti za dioničare, dok padajući ROE može ukazivati na probleme u generiranju dobiti ili upravljanju vlastitim kapitalom.

Utjecaj na investicije

ROE od Alcon je ključan za investitore koji procjenjuju profitabilnost, učinkovitost i privlačnost tvrtke kao investicije. Snažna ROE ukazuje na sposobnost tvrtke da pretvori investicije vlastitog kapitala u dobit, time povećavajući svoju privlačnost potencijalnim i postojećim investitorima.

Interpretacija fluktuacija ROE

Promjene u ROE od Alcon mogu rezultirati iz fluktuacija neto dobiti, vlastitog kapitala ili oboje. Te se fluktuacije proučavaju kako bi se procijenila učinkovitost upravljanja, financijske strategije te povezani rizici i mogućnosti, i kako bi se investitorima pomoglo u donošenju informiranih odluka.

Često postavljana pitanja o dionici Alcon

ROE (Return on Equity) tvrtke Alcon iznosi 4,66 % u 2026. godini.

ROE (Return on Equity) tvrtke Alcon se promijenio s 4,72 % na 4,66 %, što predstavlja promjenu od −1,29 %. Vrijednost je manji nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni povijesni razvoj Alcon tvrtke ROE (Return on Equity) od 2006. – s godišnjim vrijednostima, grafikonima i detaljnim analizama.

Dobra vrijednost za varira po branši i fazi razvoja. Na Eulerpool-u možete usporediti ROE (Return on Equity)s Alcon sa sličnim poduzećima u sektoru i prosječnom vrijednosti u industriji kako biste procijenili je li privlačna.

Za procjenu ROE (Return on Equity)s, bitno je usporediti ga s konkurentima u istoj branši i sektoru. Na Eulerpool-u možete pronaći izravne usporedbe s industrijom za ROE (Return on Equity).

Access this data via the Eulerpool API

Profitabilnost — Alcon

Sve ključne metrike — Alcon